Comments
Loading...

Bausch Health Companies

BHCNYSE
Logo brought to you by Benzinga Data
$8.18
0.162.00%
At Close: -
$8.05
-0.13-1.59%
After Hours: 4:25 PM EDT
15 minutes delayed
Consensus Rating1
Market Perform
Highest Price Target1
$16.00
Lowest Price Target1
$3.00
Consensus Price Target1
$8.42

Bausch Health Companies (NYSE:BHC) Stock, Analyst Ratings, Price Targets, Forecasts

Bausch Health Companies Inc has a consensus price target of $8.42 based on the ratings of 8 analysts. The high is $16 issued by Jefferies on September 20, 2023. The low is $3 issued by Piper Sandler on August 2, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Piper Sandler, and Truist Securities on August 2, 2024, August 2, 2024, and July 25, 2024, respectively. With an average price target of $6.17 between RBC Capital, Piper Sandler, and Truist Securities, there's an implied -23.40% downside for Bausch Health Companies Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.6
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Piper Sandler
Truist Securities
Raymond James
Jefferies

1calculated from analyst ratings

Analyst Ratings for Bausch Health Companies

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Bausch Health Companies (BHC) stock?

A

The latest price target for Bausch Health Companies (NYSE:BHC) was reported by RBC Capital on August 2, 2024. The analyst firm set a price target for $8.50 expecting BHC to rise to within 12 months (a possible 5.59% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bausch Health Companies (BHC)?

A

The latest analyst rating for Bausch Health Companies (NYSE:BHC) was provided by RBC Capital, and Bausch Health Companies maintained their sector perform rating.

Q

When was the last upgrade for Bausch Health Companies (BHC)?

A

The last upgrade for Bausch Health Companies Inc happened on September 20, 2023 when Jefferies raised their price target to $16. Jefferies previously had a hold for Bausch Health Companies Inc.

Q

When was the last downgrade for Bausch Health Companies (BHC)?

A

The last downgrade for Bausch Health Companies Inc happened on August 2, 2024 when Piper Sandler changed their price target from $9 to $3 for Bausch Health Companies Inc.

Q

When is the next analyst rating going to be posted or updated for Bausch Health Companies (BHC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch Health Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch Health Companies was filed on August 2, 2024 so you should expect the next rating to be made available sometime around August 2, 2025.

Q

Is the Analyst Rating Bausch Health Companies (BHC) correct?

A

While ratings are subjective and will change, the latest Bausch Health Companies (BHC) rating was a maintained with a price target of $10.00 to $8.50. The current price Bausch Health Companies (BHC) is trading at is $8.05, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.